By API User
Key Highlights: PANCOSIL is the first in the world study administering OncoSil™ via direct injection through the skin (percutaneous) under CT-imaging guidance for treatment of locally advanced pancreatic cancer (LAPC) Preliminary results from the PANCOSIL Investigator Initiated Study presented at the CIRSE 2025 Congress demonstrate it is both safe and feasible to deliver OncoSil™ by … Continued
By API User
In a rare and significant milestone for an Australian-discovered therapy, Pfizer Inc has commenced a Phase 3 clinical trial to study a potential new medicine for advanced breast cancer, based on pioneering research from Monash University and the Cancer Therapeutics Cooperative Research Centre (CTx). The first-in-class therapy is being studied as a treatment in adults … Continued
By API User
A Monash University-led study published in JAMA Network Open was the first to examine the impact of pregnancy on multiple sclerosis (MS) relapse activity and long-term disability progression in women with moderate to severe disability. Most previous research has focused on women with mild MS-related disability. Similar to findings in women with minimal disability, MS … Continued
By API User
MEDIA RELEASE Thursday 18 September 2025 The silent crisis no one talks about: ‘On The Down Low’ podcast returns to raise awareness of one of Australia’s fastest growing women’s cancers Uterine cancers (including endometrial cancer) are the fastest growing women’s cancer in Australia, yet they remain largely unknown, underfunded, and under-researched. Each year, close to … Continued
By API User
Universal Surveillance Monitoring with Masimo SET® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to Improve Patient Outcomes and Save Lives – Also Projected to Yield Significant Cost Savings IRVINE, Calif.–BUSINESS WIRE– Masimo (NASDAQ: MASI) today announced the findings of a study published in the Journal of Patient Safety in which Dr. George Blike and … Continued
By API User
IRVINE, Calif.–BUSINESS WIRE– SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the launch of a new brand, “Hada no Aozora Clinic”, scheduled to open in Tokyo on October 1, 2025. This clinic will adopt a hybrid … Continued
By API User
Four-year data show nearly 9 in 10 RMS patients remained free from progression independent of relapse activity (PIRA) Results highlight the potential of MAVENCLAD to reduce neurodegeneration and neuroinflammation beyond established clinical efficacy outcomes in RMS Evidence suggests that MAVENCLAD effectiveness could be driven by peripheral and central effects without requiring continuous immunosuppression DARMSTADT, Germany–BUSINESS … Continued
By API User
Results from a real-world clinical study conducted in China, to be presented at the European Academy of Dermatology and Venereology (EADV) 2025 Congress, reveal that modern lifestyles and environmental triggers significantly impact individuals with sensitive skin1 Data show that people with sensitive skin living in modern environments have higher levels of inflammation compared to those … Continued
By API User
The Australian College of Nursing (ACN) welcomes the New South Wales and Queensland governments’ introduction of an intranasal influenza vaccine (FluMist) for children aged two to under five years, which will address some but not all of the barriers to childhood immunisation. ACN CEO Adjunct Professor Kathryn Zeitz said subjecting a child to an injection … Continued
By API User
Key Facts: When parents separate in Australia, their futures – and their children’s – often rely on the words chosen by judges in the Family Court. But those words aren’t always neutral along gender lines, say a team of UNSW researchers. The language chosen by judges in the Australian family courts reflects and reinforces long-standing … Continued
